CADY-2e (SEQ ID No: 12)

General Information


DRACP ID  DRACP05291

Peptide Name   CADY-2e (SEQ ID No: 12)

Sequence  GLWRALWRLLRSLWRLLWSQPKKKRKV

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Cysteamide group

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C166H269N51O31

Absent amino acids  CDEFHIMNTY

Common amino acids  L

Mass  393922

Pl  13.11

Basic residues  9

Acidic residues  0

Hydrophobic residues  13

Net charge  9

Boman Index  -5859

Hydrophobicity  -60

Aliphatic Index  115.56

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  22000

Absorbance 280nm  846.15

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US7943581B2

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1720

DRACP is developed by Dr.Zheng's team.